Landscapes / Companies
Praxis Precision Medicines not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 in Phase 3
2 in Phase 2
Drugs
6
in active trials · 8 in all
Trials
8 active
16 since 2021
Drugs6
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Dec 2026Phase 3 trial completes | |||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Epileptic Encephalopathy, SCN2A Encephalopathy | ||||
| Open drug page | |||||
— |
Phase 3 | Dec 2026Phase 3 trial completes | |||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | SCN2A Encephalopathy, SCN8A Encephalopathy and 1 more | ||||
| Open drug page | |||||
— |
Phase 3 | Jan 2027Phase 3 trial completes | |||
| Next date | Jan 2027 · Phase 3 trial completes | ||||
| Also tested for | Epilepsy, Tonic-Clonic, Focal Seizure and 2 more | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Essential Tremor | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | SCN2A-DEE, Epilepsy | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Focal Onset Seizure, Primary Generalized Epilepsy | ||||
| Open drug page | |||||
About
- No active trial
- Flexibly dosed, PRAX-114
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021